Gail Colbern

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

John W. Park, Keelung Hong, Dmitri B. Kirpotin et al. · PubMed · 2002 · 648 citations

Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice

Mary S. Newman, Gail Colbern, Peter K. Working et al. · Cancer Chemotherapy and Pharmacology · 1999 · 273 citations

Oncology, Medicine, Tumor Targeting +7

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

William C. Zamboni, Anne Gervais, Merrill J. Egorin et al. · Cancer Chemotherapy and Pharmacology · 2004 · 163 citations

Tumor Disposition, Medicine, Melanoma +9

Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta

Gail Colbern, Mimi H. Chiang, Elliott K. Main · American Journal of Obstetrics and Gynecology · 1994 · 110 citations

Hla, Histocompatibility, Maternal Immunization +11

STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial

David M. Vail, Ilene D. Kurzman, P. Glawe et al. · Cancer Chemotherapy and Pharmacology · 2002 · 90 citations

Surgical Oncology, Oncology, Medicine +8